EU drugs panel gives final no to Genta's Genasense

LONDON, July 19 (Reuters) - The European Medicines Agency said on Thursday it had adopted a final negative opinion on Genta's GNTA.O metastatic melanoma drug Genasense.

"Following the re-examination of the negative opinion adopted on 26 April 2007, the CHMP confirmed its previous position and adopted a final negative opinion for Genasense," a committee of experts at the European Medicines Agency said in a statement.